• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
DARE

DARE

Daré Bioscience, Inc.

NASDAQHealthcareBiotechnologyUS

USD2.05

-0.09 (-4.21%)

Rating:C-

Company Profile

CEO

Sabrina Martucci Johnson

IPO Date

2014-04-10

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$2.12

Prev. Close

$2.14

Day Low

$2.03

Day High

$2.24

52W Low

$1.27

52W High

$9.19

Market Cap

$0.02B

Volume

0.21M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

22.8%

Avg Negative

4.3%

Avg Neutral

72.7%

News Feed

Hot Penny Stocks to Watch Right Now, Have You Heard of These 3?

PennyStocks·8/19/2021·↓ negative

3 Penny Stocks on Reddit That Traders Are Buying Right Now

PennyStocks·8/15/2021·↓ negative

Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/13/2021·↓ negative

Daré Bioscience Stock Is Trading Higher As Bacterial Vaginosis Candidate Secures FDA Priority Review

Benzinga·8/9/2021·↑ positive

Top Penny Stocks to Watch to Start Your Week Off Right

PennyStocks·8/2/2021·↓ negative

Daré Bioscience to Present at the 2021 Controlled Release Society Virtual Annual Meeting to be held July 25-29, 2021

GlobeNewsWire·7/26/2021·↑ positive

High Volume Penny Stocks to Watch After The Market Crash

PennyStocks·7/20/2021·↓ negative

Daré Announces Collaborative Research Agreement (CRADA) for the Pivotal Phase 3 Study of Ovaprene®, an Investigational Hormone-Free Monthly Contraceptive

GlobeNewsWire·7/12/2021·↑ positive

Dare Bioscience Stock Increased 23.68%: Why It Happened

Pulse2·7/8/2021·↑ positive

DARE Stock: Why Did ‘Gates' Give Dare Bioscience a $49M Grant?

InvestorPlace·7/7/2021·↑ positive